Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen von Murphy, G., Tjoa, B., Ragde, H., Kenny, G., Boynton, A.

Volltext

Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castrati... von Thomsen, L.C.V., Honoré, A., Almås, B., Reisæter, L.A.R., Førde, K., Kristoffersen, E.K., Kaada, S.H., Melve, G.K., Helle, S.I., Kvalheim, G., Azeem, W., Olsen, J.R., Halvorsen, O.J., Akslen, L.A., Bahn, D., Pantel, K., Riethdorf, S., Ragde, H., Gjertsen, B.T., Øyan, A.M., Kalland, K.H., Beisland, C.

Volltext

Follow-up evaluation of a phase II prostate cancer vaccine trial von Tjoa, B.A., Simmons, S.J., Elgamal, A., Rogers, M., Ragde, H., Kenny, G.M., Troychak, M.J., Boynton, A.L., Murphy, G.P.

Volltext

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refrac... von Murphy, G.P., Tjoa, B.A., Simmons, S.J., Jarisch, J., Bowes, V.A., Ragde, H., Rogers, M., Elgamal, A., Kenny, G.M., Cobb, O.E., Ireton, R.C., Troychak, M.J., Salgaller, M.L., Boynton, A.L.

Volltext

Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment von Murphy, G.P., Tjoa, B.A., Simmons, S.J., Ragde, H., Rogers, M., Elgamal, A., Kenny, G.M., Troychak, M.J., Salgaller, M.L., Boynton, A.L.

Volltext

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides von Tjoa, B.A., Simmons, S.J., Bowes, V.A., Ragde, H., Rogers, M., Elgamal, A., Kenny, G.M., Cobb, O.E., Ireton, R.C., Troychak, M.J., Salgaller, M.L., Boynton, A.L., Murphy, G.P.

Volltext

Modern prostate brachytherapy von Ragde, H, Grado, G. L, Nadir, B, Elgamal, A. A

Volltext

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides von Tjoa, B.A., Erickson, S.J., Bowes, V.A., Ragde, H., Kenny, G.M., Cobb, O.E., Ireton, R.C., Troychak, M.J., Boynton, A.L., Murphy, G.P.

Volltext

GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial von Simmons, S.J., Tjoa, B.A., Rogers, M., Elgamal, A., Kenny, G.M., Ragde, H., Troychak, M.J., Boynton, A.L., Murphy, G.P.

Volltext

Radiotherapy for prostate cancer: Brachytherapy alone von Ragde, Haakon

Volltext

Ten‐year disease free survival after transperineal sonography‐guided iodine‐125 brachytherapy with or without 45‐gray external beam irradiation in the treatment of patients with cl... von Ragde, Haakon, Elgamal, Abdel‐Aziz A., Snow, Peter B., Brandt, Jeff, Bartolucci, Alfred A., Nadir, Brad S., Korb, Leroy J.

Volltext

Brachytherapy for prostate cancer von Porter, A. T, Blasko, J. C, Grimm, P. D, Reddy, S. M, Ragde, H

Volltext

Prostate cancer brachytherapy von Ragde, H

Volltext

Interstitial iodine‐125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma von Ragde, Haakon, Blasko, John C., Grimm, Peter D., Kenny, Gerald M., Sylvester, John E., Hoak, David C., Landin, Kent, Cavanagh, William

Volltext

An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow‐up von Vicini, Frank A., Martinez, Alvaro, Hanks, Gerald, Hanlon, Alex, Miles, Brian, Kernan, Ken, Beyers, David, Ragde, Haakon, Forman, Jeffrey, Fontanesi, James, Kestin, Larry, Kovacs, Gyorgy, Denis, Louis, Slawin, Kevin, Scardino, Peter

Volltext

Reduction of radioactive seed embolization to the lung following prostate brachytherapy von Tapen, Elizabeth M, Blasko, John C, Grimm, Peter D, Ragde, Haakon, Luse, Ray, Clifford, Stephanie, Sylvester, John, Griffin, Thomas W

Volltext

Ultrasound-guided prostate biopsy Biopty gun superior to aspiration von Ragde, Haakon, Aldape, Hector C., Bagley, Charles M.

Volltext

Workgroup 3: Current prognostic factors and their relevance to staging von Hutter, Robert V. P., Montie, James E., Busch, Christer, Grignon, David J., Lieber, Michael, Logothetis, Christopher, Ragde, Haakon, Reuter, Victor E.

Volltext

Measurement of prostate-specific membrane antigen in the serum with a new antibody von Murphy, G. P., Tino, W. T., Holmes, E. H., Boynton, A. L., Erickson, S. J., Bowes, V. A., Barren, R. J., Tjoa, B. A., Misrock, S. L., Ragde, H., Kenny, G. M.

Volltext

Brachytherapy and organ preservation in the management of carcinoma of the prostate von Blasko, John C., Grimm, Peter D., Ragde, Haakon

Volltext